Frazier Healthcare V
Frazier Healthcare V, established in 1991, is a Seattle-based private equity firm with a focus on the healthcare sector. With over $2 billion under management, the firm invests in growth capital for healthcare companies, spanning from venture capital to growth buyouts. Frazier Healthcare V primarily invests in life science, healthcare devices and supplies, pharmaceuticals, and biotechnology sectors, demonstrating a commitment to innovation and unmet medical needs. The firm takes an active approach to portfolio management, leveraging its deep domain expertise and extensive network of industry thought leaders.
SanReno Therapeutics
Funding Round in 2021
SanReno Therapeutics specializes in the development, manufacturing, and commercialization of therapies for kidney diseases in several regions including the People's Republic of China, Hong Kong, Macau, Taiwan, and Singapore. Established through a joint venture involving Chinook Therapeutics, Frazier Healthcare Partners, and Pivotal bioVenture Partners China, the company is dedicated to researching and producing innovative biotech solutions aimed at improving the quality of life for patients suffering from kidney-related conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.